I am a
Home I AM A Search Login

Papers of the Week

2020 Apr 06

J Chromatogr B Analyt Technol Biomed Life Sci


Determination of urinary prostaglandin E as a potential biomarker of ureteral stent associated inflammation.


Huang Z-A, Scotland KB, Li Y, Tan J, Kung SHY, Chew BH, Chen DDY, Lange D
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Apr 06; 1145:122107.
PMID: 32315976.


Ureteral stents are the most widely used surgical implant in urology. However, they may cause adverse effects to patients, including pain, discomfort, and inflammation. In this work, the inflammatory effect of stent placement and the associated elevation of cyclooxygenase-2 (COX-2) expression were observed. Furthermore, a capillary electrophoresis mass spectrometry (CE-MS) based approach was subsequently developed to quantify urinary prostaglandin E (PGE), a COX-2 metabolite known to contribute to inflammatory renal diseases, to further interrogate the role of this pathway. Urine samples were cleaned and preconcentrated by solid-phase extraction (SPE), and an on-line sample stacking method was used for the enrichment of analytes. The accuracy, precision, and specificity of this method were validated. Standard addition methods were performed to assess the reliability of using deuterated internal standards (IS) in compensating the remaining matrix effect after SPE as well as the detector fluctuation. Through the analysis of 32 pig urine samples, a statistically significant increase of PGE was observed in the stented group compared to the unstented (P = 0.01) and the recovered (P = 0.004) groups. This work determined that stent placement may contribute to COX-2-dependent inflammation and developed a reliable CE-MS based methodology to quantify PGE in stented individuals that may further understand the biology of stent-associated inflammation and inform urologic patient management.